Page 348 - Chiral Separation Techniques

References 341
[7] A. J. Hutt, S. C. Tan, Drug chirality and its clinical significance, Drugs, 1996, 52 (Suppl 5), 1–12.
[8] D. J. Triggle, Drug Discovery Today, 1997, 2, 138–147.
[9] J. Caldwell, Importance of stereospecific bioanalytical monitoring in drug development, J. Chro-
matogr. A 1996, 719, 3–13.
[10] M. Gross, A. Cartwright, B. Campbell, R. Bolton, K. Holmes, K. Kirkland, T. Salmonson, J.-L.
Robert. Regulatory Requirements for chiral drugs, Drug Information J. 1993, 27, 453–457.
[11] A. G. Rauws, K. Groen, Current regulatory (draft) guidance on chiral medicinal products: Canada,
EEC, Japan, United States, Chirality, 1994, 6, 72–75.
[12] R. R. Shah, J. M. Midgley, S. K. Branch, Stereochemical origin of some clinically significant drug
safety concerns: lessons for future drug development, Adverse Drug React. Toxicol. Rev. 1998, 17,
145–190.
[13] P. J. Hayball, Chirality and nonsteroidal anti-inflammatory drugs, Drugs, 1996, 52 (Suppl. 5),
47–58.
[14] A. J. Hutt, J. O’Grady, Drug chirality: a consideration of the significance of the stereochemistry of
antimicrobial drugs, J. Antimicrobial Chemother., 1996, 37, 7–32.
[15] Eudralex: The rules governing medicinal products in the European Union, Vols. 1–9, Office for
Official Publications of the European Communities, Luxembourg, 1998.
[16] European Pharmacopoeia technical guide for elaboration of monographs 2 nd ed. Pharmeuropa,
Special Issue, November 1996.
[17] H. Shindo, J. Caldwell, Regulatory aspects of the development of chiral drugs in Japan: a status
report, Chirality, 1991, 3, 91–93.
[18] H. Shindo, J. Caldwell, Development of chiral drugs in Japan: an update on regulatory and indus-
trial opinion, Chirality, 1995, 7, 349–352.
[19] E. J. Ariëns, E. W. Wuis, E. J. Verings, Stereoselectivity of bioactive xenobiotics, Biochem. Phar-
macol. 1988, 37, 9–15.
[20] J. S. Millership, A. Fitzpatrick, Commonly used chiral drugs: a survey, Chirality, 1993, 5, 573–576.
[21] D. Mauleon, R. Artigas, M. L. Garcia, G. Carganico, Pre-clinical and clinical development of
dexketoprofen, Drugs, 1996, 52 (Suppl. 5) 24–46.